Tuberculosis News and Research RSS Feed - Tuberculosis News and Research

Tuberculosis (TB) is a bacterial infection caused by a germ called Mycobacterium tuberculosis. The bacteria usually attack the lungs, but they can also damage other parts of the body. TB spreads through the air when a person with TB of the lungs or throat coughs, sneezes or talks. If you think you have been exposed, you should go to your doctor for tests as soon as possible. You are more likely to get TB if you have a weak immune system.
Hospira announces availability of INFLECTRA (infliximab) in Canada

Hospira announces availability of INFLECTRA (infliximab) in Canada

Hospira, Inc., a global leader in biosimilars and the world's leading provider of injectable drugs and infusion technologies, announces the availability of INFLECTRA (infliximab) in Canada, the country's first subsequent entry biologic (SEB) monoclonal antibody (mAb) therapy. [More]
TB Alliance, U.S. Fund for UNICEF partner to bring new TB treatments for children

TB Alliance, U.S. Fund for UNICEF partner to bring new TB treatments for children

TB Alliance has announced a new partnership with the U.S. Fund for UNICEF that will dramatically increase the scope and impact of child and maternal health programs around the world to include the diagnosis and treatment of pediatric tuberculosis (TB), a significant cause of child mortality. [More]
Mayo Clinic Center for Tuberculosis introduces new medical journal

Mayo Clinic Center for Tuberculosis introduces new medical journal

The Mayo Clinic Center for Tuberculosis, a regional training and consultation center at Mayo Clinic's campus in Rochester, Minn, is today launching a new medical journal, the Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. [More]
TB Alliance receives Australian DFAT grant to support late-stage clinical trials of new TB drugs

TB Alliance receives Australian DFAT grant to support late-stage clinical trials of new TB drugs

TB Alliance, a not-for-profit product development partnership with the mission of developing better, faster, and affordable drugs for tuberculosis (TB), has received a grant from the Australian Department of Foreign Affairs and Trade to support late-stage clinical trials of new TB treatments. [More]
The fight continues to end tuberculosis

The fight continues to end tuberculosis

Today is World TB Day. The Centenary Institute is one of the leading medical research institutes in Australia championing the fight to put an end to this insidious disease. [More]
Researchers use genetic information to track the fatal spread of multidrug-resistant TB

Researchers use genetic information to track the fatal spread of multidrug-resistant TB

Scientists have for the first time used DNA sequencing to trace the fatal spread of multidrug-resistant tuberculosis between patients in the UK. [More]
Scientists use DNA sequencing to trace the spread of drug-resistant TB

Scientists use DNA sequencing to trace the spread of drug-resistant TB

Scientists have for the first time used DNA sequencing to trace the fatal spread of multidrug-resistant tuberculosis between patients in the UK. [More]
EMA approves Baylor's hollow fiber system for development of TB drugs

EMA approves Baylor's hollow fiber system for development of TB drugs

The European Medicines Agency (EMA), the equivalent of the U.S. Food and Drug Administration, has approved the use of the hollow fiber system for the development of drugs to treat and prevent tuberculosis (TB). [More]
Glyxambi for Type 2 diabetes treatment now available by prescription across the U.S.

Glyxambi for Type 2 diabetes treatment now available by prescription across the U.S.

Glyxambi® (empagliflozin/linagliptin) tablets are now available by prescription in many leading chain and independent pharmacies across the U.S., including Walgreens and Rite Aid. [More]
Cosentyx (secukinumab) safe, effective for treating psoriasis patients

Cosentyx (secukinumab) safe, effective for treating psoriasis patients

Novartis today announced new two-year results demonstrating sustained efficacy with Cosentyx (secukinumab) with an acceptable safety profile for the treatment of psoriasis patients. The data comes from the extension study of the pivotal Phase III FIXTURE and ERASURE trials. [More]
Healthcare systems miss life-saving treatments learnt on battlefield

Healthcare systems miss life-saving treatments learnt on battlefield

Trauma is responsible for more global deaths annually than HIV, malaria and tuberculosis combined. Yet healthcare systems in many countries are missing out on life-saving treatments learnt on the battlefield, according to a review by King's College London and published today in the Journal of the Royal Society of Medicine. [More]
New technology developed to determine resistance to rabies virus

New technology developed to determine resistance to rabies virus

Researchers at Texas A&M AgriLife Research have developed a new technology to determine sensitivity or resistance to rabies virus. [More]
Janssen announces acquisition of XO1

Janssen announces acquisition of XO1

Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has acquired XO1 Limited, a privately held asset-centric virtual biopharmaceutical company founded to develop the anti-thrombin antibody ichorcumab. [More]
PaMZ drug regimen shows potential to improve treatment for MDR-TB

PaMZ drug regimen shows potential to improve treatment for MDR-TB

A new tuberculosis (TB) drug regimen designed to improve options for TB therapy eliminated more bacteria from sputum than standard therapy and did so at a faster rate, according to data from a phase 2b clinical trial published today in The Lancet. These results are published just as the global phase 3 clinical trial, designed to bring this regimen through the last stage of testing, has begun. [More]
American Cancer Society, World Lung Foundation unveil ‘The Tobacco Atlas, Fifth Edition’

American Cancer Society, World Lung Foundation unveil ‘The Tobacco Atlas, Fifth Edition’

The Tobacco Atlas, Fifth Edition ("The Atlas"), and its companion mobile app and website TobaccoAtlas.org, were unveiled today by the American Cancer Society and World Lung Foundation at the 16th World Conference on Tobacco or Health. [More]
World Health Organisation (WHO) joins with ESCMID to fight global infections

World Health Organisation (WHO) joins with ESCMID to fight global infections

The European Society for Clinical Microbiology and Infectious Diseases (ESCMID) has been joined by the World Health Organisation (WHO) to launch the 7th annual ‘International Day for Fighting Infection’ (April 24th, 2015). [More]
Study: Countries most affected by Ebola outbreak may soon have 100,000 more measles cases

Study: Countries most affected by Ebola outbreak may soon have 100,000 more measles cases

An international study involving the University of Southampton suggests there could be a rise in measles cases of 100,000 across the three countries most affected by the Ebola outbreak in West Africa due to health system disruptions. [More]
GHTC report confronts key challenge of renewing US leadership in global health technology

GHTC report confronts key challenge of renewing US leadership in global health technology

​Today, the world is looking to the United States for cutting-edge diagnostics, drugs, and vaccines that could have the last word on an Ebola outbreak that is down but not out. But those innovations are the product of past US investments in research and development (R&D). [More]
Ebola crisis increases susceptibility to measles, other vaccine-preventable illnesses

Ebola crisis increases susceptibility to measles, other vaccine-preventable illnesses

Johns Hopkins Bloomberg School of Public Health researchers say that major disruptions in the health care systems in West Africa caused by the Ebola crisis have led to significant decreases in vaccinations for childhood diseases, increasing susceptibility to measles and other vaccine-preventable illnesses. [More]
New X-ray diagnostic imaging designed to meet the needs of hospitals in developing countries

New X-ray diagnostic imaging designed to meet the needs of hospitals in developing countries

In developing countries, many hospitals have become cemeteries of medical equipment. Several radiology systems, often sent by international aid, may never be used due to the climatic conditions and the instability of electricity networks. In a matter of weeks, they become useless. Besides, the lack of qualified personnel or spare parts rapidly dispels any hope to make them work. Yet, the lack of access to radiology in many developing countries is a serious public health problem, whether for TB screening or the care of road traffic injuries. [More]
Advertisement
Advertisement